4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-19-038099
SVP & Chief Financial Officer sold 25,000 shares at $33.71 ($842,750)
- SVP & Chief Financial Officer acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Labrucherie Gil M SVP & Chief Financial Officer | 2019-06-17 | Option exercise | +25,000 | $7.21 | $180,250 | 152,935 | D: show line 1 in the form |
| Labrucherie Gil M SVP & Chief Financial Officer | 2019-06-17 | Sale | −25,000 | $33.71 | $842,750 | 127,935 | D: show line 2 in the form |
| Open-market sales · 25,000 sh · avg $33.71 · $842,750 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Labrucherie Gil M SVP & Chief Financial Officer | 2019-06-17 | Option exercise · Stock Option | −25,000 | 50,000 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…